Ken Griffin’s Citius Pharmaceuticals CTXR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 6005 |
|
|
2025
Q1 | – | Sell |
-1
| Closed | -$4 | – | 6093 |
|
|
2024
Q4 | $4 | Buy |
+1
| New | +$4 | ﹤0.01% | 5903 |
|
|
2024
Q3 | – | Sell |
-185,614
| Closed | -$108K | – | 5919 |
|
|
2024
Q2 | $108K | Buy |
+185,614
| New | +$108K | ﹤0.01% | 4923 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6203 |
|
|
2023
Q4 | – | Sell |
-4,851
| Closed | -$3.32K | – | 5991 |
|
|
2023
Q3 | $3.32K | Buy |
4,851
+4,064
| +516% | +$2.78K | ﹤0.01% | 5565 |
|
|
2023
Q2 | $944 | Sell |
787
-86,524
| -99% | -$104K | ﹤0.01% | 5627 |
|
|
2023
Q1 | $102K | Sell |
87,311
-304,862
| -78% | -$357K | ﹤0.01% | 4901 |
|
|
2022
Q4 | $310K | Buy |
392,173
+285,795
| +269% | +$226K | ﹤0.01% | 4298 |
|
|
2022
Q3 | $129K | Sell |
106,378
-129,492
| -55% | -$157K | ﹤0.01% | 5023 |
|
|
2022
Q2 | $217K | Buy |
235,870
+123,849
| +111% | +$114K | ﹤0.01% | 4933 |
|
|
2022
Q1 | $200K | Sell |
112,021
-26,093
| -19% | -$46.6K | ﹤0.01% | 5318 |
|
|
2021
Q4 | $213K | Buy |
138,114
+22,741
| +20% | +$35.1K | ﹤0.01% | 5428 |
|
|
2021
Q3 | $234K | Sell |
115,373
-93,835
| -45% | -$190K | ﹤0.01% | 5254 |
|
|
2021
Q2 | $728K | Buy |
209,208
+181,199
| +647% | +$631K | ﹤0.01% | 4360 |
|
|
2021
Q1 | $50K | Buy |
28,009
+9,118
| +48% | +$16.3K | ﹤0.01% | 6097 |
|
|
2020
Q4 | $19K | Buy |
+18,891
| New | +$19K | ﹤0.01% | 4982 |
|
|
2020
Q3 | – | Sell |
-17,437
| Closed | -$20K | – | 4747 |
|
|
2020
Q2 | $20K | Buy |
17,437
+6,785
| +64% | +$7.78K | ﹤0.01% | 4486 |
|
|
2020
Q1 | $6K | Buy |
+10,652
| New | +$6K | ﹤0.01% | 4770 |
|
|
2019
Q2 | – | Sell |
-26,568
| Closed | -$38K | – | 4704 |
|
|
2019
Q1 | $38K | Buy |
+26,568
| New | +$38K | ﹤0.01% | 4297 |
|